Severe influenza treatment guideline

نویسندگان

  • Won Suk Choi
  • Ji Hyeon Baek
  • Yu Bin Seo
  • Sae Yoon Kee
  • Hye Won Jeong
  • Hee Young Lee
  • Byung Wook Eun
  • Eun Ju Choo
  • Jacob Lee
  • Young Keun Kim
  • Joon Young Song
  • Seong-Heon Wie
  • Jin Soo Lee
  • Hee Jin Cheong
  • Woo Joo Kim
چکیده

Won Suk Choi, Ji Hyeon Baek, Yu Bin Seo, Sae Yoon Kee, Hye Won Jeong, Hee Young Lee, Byung Wook Eun, Eun Ju Choo, Jacob Lee, Young Keun Kim, Joon Young Song, Seong-Heon Wie, Jin Soo Lee, Hee Jin Cheong, Woo Joo Kim, and Transgovernmental Enterprise for Pandemic Influenza in Korea Department of Internal Medicine, Korea University College of Medicine, Seoul; Department of Internal Medicine, Inha University School of Medicine, Incheon; Department of Internal Medicine, Hallym University College of Medicine, Seoul; Department of Internal Medicine, Konkuk University School of Medicine, Chungju; Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju; Gachon University Gil Hospital Cancer Center, Gachon University Gil Medical Center, Incheon; Department of Pediatrics, Eulji University School of Medicine, Daejeon; Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon; Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju; Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

What Is the Optimal Therapy for Patients with H5N1 Influenza?

BACKGROUND TO THE DEBATE In a 2007 article in PLoS Medicine[10], Holger J. Schünemann and colleagues described a new process used by the World Health Organization for rapidly developing clinical management guidelines in emergency situations. These situations include outbreaks of emerging infectious diseases. The authors discussed how they developed such a "rapid advice" guideline for the pharma...

متن کامل

The Neurological Manifestations of H1N1 Influenza Infection; Diagnostic Challenges and Recommendations

Background: World Health Organization declared pandemic phase of human infection with novel influenza A (H1N1) in April 2009. There are very few reports about the neurological complications of H1N1 virus infection in the literature. Occasionally, these complications are severe and even fatal in some individuals. The aims of this study were to report neurological complaints and/or complications ...

متن کامل

The use of antiviral drugs for influenza: A foundation document for practitioners

1C INDEX I. PURPOSE II. PROCESS STATEMENT III. GRADING OF RECOMMENDATIONS IV. THE DISEASE A. Influenza viruses B. Clinical aspects C. Clinical diagnosis of influenza illness V. TREATMENT OF INFLUENZA ILLNESS A. Antiviral drugs including off-label use B. Benefits of antiviral treatment C. Considerations in selecting treatments 1. Severity of illness 2. Presence of risk factors or co-morbid medic...

متن کامل

Antioxidant therapy as a potential approach to severe influenza-associated complications.

With the appearance of the novel influenza A (H1N1) virus 2009 strain we have experienced a new influenza pandemic and many patients have died from severe complications associated with this pandemic despite receiving intensive care. This suggests that a definitive medical treatment for severe influenza-associated complications has not yet been established. Many studies have shown that superoxid...

متن کامل

Influenza: A Unique Disease

Dear Editor-in-Chief, Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus (1). Symptoms can be mild to severe (2). The most common symptoms include: high fever, runny nose, sore throat, muscle pains, headache, coughing, sneezing, and feeling tired (1). Three of the four types of influenza viruses affect people, Type A, Type B, and Type C (3, 4). Type D ha...

متن کامل

The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza

Influenza A viruses are a major cause of mortality. Given the potential for future lethal pandemics, effective drugs are needed for the treatment of severe influenza such as that caused by H5N1 viruses. Using mediator lipidomics and bioactive lipid screen, we report that the omega-3 polyunsaturated fatty acid (PUFA)-derived lipid mediator protectin D1 (PD1) markedly attenuated influenza virus r...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 29  شماره 

صفحات  -

تاریخ انتشار 2014